Plasmid pBR322 has PstI restriction enzyme site within gene ampR that confers ampicillin resistance.If this enzymes is used for inserting a gene - galactoside production and the recombinant plasmid is inserted in an E.coli strain
it will not be able to confer ampicilin resistance to the host cell
the transformed cells will have the ability to resist ampicillin as well as produces - galactoside
it will lead to lysis of host cell
it will be able to produce a novel protein with dual ability
Since the gene is inserted at Pst I of ampR region of pBR322, the ampR gene is inactivated which is called as insertional inactivation. Hence the genetically modified E. coli strain will not be able to confer ampicillin resistance.